[go: up one dir, main page]

AU2002218419A1 - Topical alcoholic solution of a salicylic acid derivative and acemannan - Google Patents

Topical alcoholic solution of a salicylic acid derivative and acemannan

Info

Publication number
AU2002218419A1
AU2002218419A1 AU2002218419A AU1841902A AU2002218419A1 AU 2002218419 A1 AU2002218419 A1 AU 2002218419A1 AU 2002218419 A AU2002218419 A AU 2002218419A AU 1841902 A AU1841902 A AU 1841902A AU 2002218419 A1 AU2002218419 A1 AU 2002218419A1
Authority
AU
Australia
Prior art keywords
salicylic acid
acemannan
acid derivative
solution
physiologically tolerable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218419A
Other languages
English (en)
Inventor
Jo Klaveness
Henrik Steenfeldt-Foss
Per Stanley Thrane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORWAY MEDICAL GROUP INT AS
Original Assignee
NORWAY MEDICAL GROUP INT AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORWAY MEDICAL GROUP INT AS filed Critical NORWAY MEDICAL GROUP INT AS
Publication of AU2002218419A1 publication Critical patent/AU2002218419A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU2002218419A 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan Abandoned AU2002218419A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0029634.3A GB0029634D0 (en) 2000-12-05 2000-12-05 Use
GB0029634 2000-12-05
PCT/GB2001/005380 WO2002045687A2 (fr) 2000-12-05 2001-12-05 Utilisation

Publications (1)

Publication Number Publication Date
AU2002218419A1 true AU2002218419A1 (en) 2002-06-18

Family

ID=9904475

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218419A Abandoned AU2002218419A1 (en) 2000-12-05 2001-12-05 Topical alcoholic solution of a salicylic acid derivative and acemannan

Country Status (4)

Country Link
EP (1) EP1349540A2 (fr)
AU (1) AU2002218419A1 (fr)
GB (1) GB0029634D0 (fr)
WO (1) WO2002045687A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
WO2005077379A1 (fr) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd. Remede a usage externe pour lesions de la peau et des muqueuses causees par infection virale
FR3130556A1 (fr) * 2021-12-16 2023-06-23 L'oreal Utilisation d’acide salicylique et/ou de ses dérivés et/ou de leurs sels, pour augmenter ou restaurer la perception tactile cutanée
WO2025114578A1 (fr) 2023-11-29 2025-06-05 Auxesis Pharma Holding Ab (Publ) Composition et son utilisation comme médicament

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
US4942031A (en) * 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5034221A (en) * 1989-06-22 1991-07-23 Rosen Steven E Topical agent and method for the treatment of Pseudofolliculitis barbae
IT1230922B (it) * 1989-06-23 1991-11-08 Giuseppe De Benedittis Composizione per il trattamento della nevralgia erpetica acuta e della nevralgia post erpetica
EP0639068A1 (fr) * 1992-05-05 1995-02-22 The Procter & Gamble Company Composition de traitement de l'acne
US5736126A (en) * 1996-03-15 1998-04-07 Van Engelen; H. Wayne Liquid transdermal analgesic
GB9914582D0 (en) * 1999-06-22 1999-08-25 Us Analgesic Group Inc Composition

Also Published As

Publication number Publication date
WO2002045687A2 (fr) 2002-06-13
EP1349540A2 (fr) 2003-10-08
WO2002045687A3 (fr) 2003-04-10
GB0029634D0 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
ES2207023T3 (es) Composiciones que comprenden una combinacion de una base esfingoide libre y una ceramida y utilizacion de las mismas.
ES2299258T3 (es) Compuesto esponjoso.
Goh et al. Formulation of diclofenac for dermal delivery
JP4555111B2 (ja) 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体
IL167057A (en) Aggregate with increased deformability, comprising a bilayer- forming lipid, an amphipathic analgesic drug, and a surfactant capable of self- aggregation in a suspension medium, for improved transport through semi- permeable barriers and for the non- invasive drug application in vivo, especially through the skin
JP2000513706A (ja) スキンケア製剤とその方法
US5045559A (en) Treatment of skin disorders
ITMI20070644A1 (it) Composizioni topiche comprendenti magaldrato
AU2002218419A1 (en) Topical alcoholic solution of a salicylic acid derivative and acemannan
WO1998010768A1 (fr) Compositions antivirales
ZA200304635B (en) Hypoallergenic and non-irritant skin care formulations.
SK284505B6 (sk) Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení
ITRM930365A1 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
KR100527346B1 (ko) 유사 세라마이드를 함유한 다중 라멜라 에멀젼 형태의 화장료
US20120053152A1 (en) (R)-(-)-1,2-propanediol compositions and methods
DE69206913T2 (de) Formulierungen zur Behandlung der vaginalen Trockenheit
WO2011138364A1 (fr) Composition topique et son utilisation pour la prophylaxie et le traitement de défauts liés à des dermatoses inflammatoires
US20080076831A1 (en) Hemorrhoid reliever and method of use
EP1146844B1 (fr) Compositions de lipides membranaires
US20150105349A1 (en) (R)-(-)-1,2-propanediol compositions and methods
KR102015890B1 (ko) 폴리사카라이드 액정 조성물과 그 제조방법 및 이를 포함하는 화장료 조성물
EP0834312B1 (fr) Préparation topique à base de diclofenac
CN104411298A (zh) 囊泡制剂、用途和方法
CA2299298A1 (fr) Compositions destinees a une administration par voie nasale
EP4342450A1 (fr) Formulations topiques hydroalcooliques de diclofénac